Literature DB >> 12664226

Epidemiologic differences in drug dependence--a US-UK cross-national comparison.

Carolyn D M Furr-Holden1, James C Anthony.   

Abstract

BACKGROUND: Published epidemiologic survey statistics do not allow direct cross-national comparison of drug dependence in the US and the UK, primarily because of a lack of uniformity across case definitions and methods of case ascertainment. AIMS: The current study sought to re-estimate these prevalence values after calibration of case definitions (i. e., imposing methodological constraints to unify case definitions), to identify suspected determinants, and also to investigate symptom profiles among active cases.
METHOD: Analyses of data from the US National Household Survey on Drug Abuse and the UK Survey of Psychiatric Morbidity were conducted. Prevalence of active drug dependence symptoms was estimated. Logistic regression analysis was used to estimate the magnitude of the association between suspected socio-demographic variables and drug dependence.
RESULTS: The prevalence of drug dependence was an estimated 1.4 % in the US and 0.5 % in the UK. This difference was somewhat attenuated when the effect of living in an urban setting was controlled. Symptom profiles among active cases were very similar. In both countries, being male, non-married, of a low socio-economic status (SES), and living in an urban setting were associated with an increased occurrence of drug dependence.
CONCLUSION: There are US-UK differences in prevalence of active drug dependence beyond what available statistics imply and some of this difference can be explained by variations associated with living in urban and rural conditions.

Mesh:

Year:  2003        PMID: 12664226     DOI: 10.1007/s00127-003-0614-7

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  6 in total

1.  Iowa Case Management for Rural Drug Abuse.

Authors:  James A Hall; Mary S Vaughan Sarrazin; Diane L Huber; Thomas Vaughn; Robert I Block; Amanda R Reedy; Mijin Jang
Journal:  Res Soc Work Pract       Date:  2009-07

Review 2.  Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review.

Authors:  Giuseppe Carrà; Sonia Johnson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-13       Impact factor: 4.328

3.  The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC).

Authors:  Giuseppe Carrà; Sonia Johnson; Paul Bebbington; Matthias C Angermeyer; Dirk Heider; Traolach Brugha; Jean-Michel Azorin; Mondher Toumi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-17       Impact factor: 5.270

4.  Prevalence and correlates of substance use among South African primary care clinic patients.

Authors:  Catherine L Ward; Jennifer R Mertens; Alan J Flisher; Graham F Bresick; Stacy A Sterling; Francesca Little; Constance M Weisner
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

5.  Prevalence of mental disorders based on general population surveys.

Authors:  Harald Baumeister; Martin Härter
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-05-21       Impact factor: 4.519

Review 6.  The effect of youth assertive community treatment: a systematic PRISMA review.

Authors:  Richard Vijverberg; Robert Ferdinand; Aartjan Beekman; Berno van Meijel
Journal:  BMC Psychiatry       Date:  2017-08-02       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.